{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:41:30Z","timestamp":1794004890574,"version":"4.8.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cardiovascular diseases as myocardial infarction (MI) represent a major cause for morbidity and mortality worldwide. Even though, patients who survive MI are susceptible to high risk of heart failure. This is mainly attributed to the major loss of cardiomyocytes and limited regenerative potential of myocardium. Despite the availability of various cardiovascular drugs, they fail to address the main cause of MI. The optimum therapeutic goal should therefore focus on enhancing cardiac regeneration through cellular and cell-free therapeutic approaches. This review focused on different mechanisms of cardiac regeneration that can be achieved via non-cellular therapeutic modalities. Passive and active targeting of the infarcted myocardium using various nanoparticles that can be loaded with growth factors, drugs or affordable natural products can reduce negative ventricular remodeling, infarct size and the apoptotic rate of cardiomyocytes. In addition, injectable biomaterials-based nanocomposite can be used as a scaffold to support infarcted heart and recruit cells. Innovative affordable and less invasive cell-free approaches can be implemented to enhance cardiac regeneration post MI.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1007\/s13346-024-01763-y","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:43:09Z","timestamp":1737398589000},"page":"2253-2271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The future of cardiac repair: a review on cell-free nanotherapies for regenerative myocardial infarction"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8998-8092","authenticated-orcid":false,"given":"Nermeen H.","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7930-483X","authenticated-orcid":false,"given":"Lamia A.","family":"Heikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3547-5404","authenticated-orcid":false,"given":"Ossama Y.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"1763_CR1","doi-asserted-by":"publisher","unstructured":"Salari N, Morddarvanjoghi F, Abdolmaleki A, Rasoulpoor S, Khaleghi AA, Hezarkhani LA, \u2026 Mohammadi M. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023;23(1), 206. https:\/\/doi.org\/10.1186\/s12872-023-03231-w","DOI":"10.1186\/s12872-023-03231-w"},{"key":"1763_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-981-10-4307-9_9","volume":"999","author":"IC Moraes-Silva","year":"2017","unstructured":"Moraes-Silva IC, Rodrigues B, Coelho-Junior HJ, Feriani DJ, Irigoyen MC. Myocardial infarction and exercise training: evidence from basic science. Adv Exp Med Biol. 2017;999:139\u201353. https:\/\/doi.org\/10.1007\/978-981-10-4307-9_9.","journal-title":"Adv Exp Med Biol"},{"key":"1763_CR3","doi-asserted-by":"publisher","unstructured":"Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, \u2026 Vasan RS. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008;118(20):2057\u20132062. https:\/\/doi.org\/10.1161\/circulationaha.108.784215.","DOI":"10.1161\/circulationaha.108.784215"},{"key":"1763_CR4","doi-asserted-by":"publisher","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, \u2026 Turner MB. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2-e220. https:\/\/doi.org\/10.1161\/CIR.0b013e31823ac046.","DOI":"10.1161\/CIR.0b013e31823ac046"},{"key":"1763_CR5","unstructured":"Dababneh E, Goldstein S. Chronic Ischemic Heart Disease Selection of Treatment Modality StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Samuel Goldstein declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC. 2024."},{"key":"1763_CR6","doi-asserted-by":"publisher","unstructured":"Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, \u2026 Task Force Members ECfPG, Document Reviewers. Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC\/ACCF\/AHA\/WHF task force for the redefinition of myocardial infarction. Eur Heart J. 2007;28(20):2525\u20132538. https:\/\/doi.org\/10.1093\/eurheartj\/ehm355.","DOI":"10.1093\/eurheartj\/ehm355"},{"key":"1763_CR7","doi-asserted-by":"publisher","unstructured":"Jangaard N, Sarkisian L, Saaby L, Mikkelsen S, Lassen A. M, Marcussen N, \u2026 Mickley H. Incidence, frequency, and clinical characteristics of type 3 myocardial infarction in clinical practice. Am J Med. 2017;130(7):862.e869\u2013862.e814. https:\/\/doi.org\/10.1016\/j.amjmed.2016.12.034.","DOI":"10.1016\/j.amjmed.2016.12.034"},{"issue":"8","key":"1763_CR8","doi-asserted-by":"publisher","first-page":"709871","DOI":"10.3389\/fcvm.2021.709871","volume":"14","author":"NN Khalil","year":"2021","unstructured":"Khalil NN, McCain ML. Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip. Frontiers in Cardiovascular Medicine. 2021;14(8):709871. https:\/\/doi.org\/10.3389\/fcvm.2021.709871.","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"5","key":"1763_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11(5):255\u201365. https:\/\/doi.org\/10.1038\/nrcardio.2014.28.","journal-title":"Nat Rev Cardiol"},{"issue":"22","key":"1763_CR10","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","volume":"121","author":"M Nahrendorf","year":"2010","unstructured":"Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010;121(22):2437\u201345. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.916346.","journal-title":"Circulation"},{"issue":"1","key":"1763_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/circresaha.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res. 2016;119(1):91\u2013112. https:\/\/doi.org\/10.1161\/circresaha.116.303577.","journal-title":"Circ Res"},{"issue":"1","key":"1763_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbadis.2016.11.006","volume":"1863","author":"AV Shinde","year":"2017","unstructured":"Shinde AV, Humeres C, Frangogiannis NG. The role of \u03b1-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta (BBA) \u2013 Mol Basis Dis. 2017;1863(1):298\u2013309. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.006.","journal-title":"Biochim Biophys Acta (BBA) \u2013 Mol Basis Dis"},{"issue":"4","key":"1763_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71(4):549\u201374. https:\/\/doi.org\/10.1007\/s00018-013-1349-6.","journal-title":"Cell Mol Life Sci"},{"key":"1763_CR14","doi-asserted-by":"publisher","unstructured":"Frangogiannis NG. Pathophysiology of myocardial infarction. Comprehensive Physiol. 2015:1841\u20131875. https:\/\/doi.org\/10.1002\/cphy.c150006.","DOI":"10.1002\/cphy.c150006"},{"issue":"1","key":"1763_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"10","author":"KT Weber","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2013;10(1):15\u201326. https:\/\/doi.org\/10.1038\/nrcardio.2012.158.","journal-title":"Nat Rev Cardiol"},{"issue":"9638","key":"1763_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/s0140-6736(08)61237-4","volume":"372","author":"HD White","year":"2008","unstructured":"White HD, Chew DP. Acute myocardial infarction. Lancet. 2008;372(9638):570\u201384. https:\/\/doi.org\/10.1016\/s0140-6736(08)61237-4.","journal-title":"Lancet"},{"issue":"1","key":"1763_CR17","first-page":"21","volume":"62","author":"P Jariwala","year":"2010","unstructured":"Jariwala P, Chandra S. Diagnosis and management of failed thrombolytic therapy for acute myocardial infarction. Indian Heart J. 2010;62(1):21\u20138.","journal-title":"Indian Heart J"},{"issue":"1 Suppl","key":"1763_CR18","doi-asserted-by":"publisher","first-page":"253s","DOI":"10.1378\/chest.119.1_suppl.253s","volume":"119","author":"EM Ohman","year":"2001","unstructured":"Ohman EM, Harrington RA, Cannon CP, Agnelli G, Cairns JA, Kennedy JW. Intravenous thrombolysis in acute myocardial infarction. Chest. 2001;119(1 Suppl):253s\u201377s. https:\/\/doi.org\/10.1378\/chest.119.1_suppl.253s.","journal-title":"Chest"},{"issue":"1","key":"1763_CR19","doi-asserted-by":"publisher","first-page":"e000735","DOI":"10.1136\/openhrt-2017-000735","volume":"5","author":"A Paul","year":"2018","unstructured":"Paul A, Diego AA, Raphael G, Henri B, Karim B. Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper. Open Heart. 2018;5(1):e000735. https:\/\/doi.org\/10.1136\/openhrt-2017-000735.","journal-title":"Open Heart"},{"key":"1763_CR20","doi-asserted-by":"publisher","unstructured":"Al-Lamee R, Thopson D, Dehbi HM, Sen S, Tang K, Davies J, \u2026 Francis DP. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018; (10115):31\u201340. https:\/\/doi.org\/10.1016\/s0140-6736(17)32714-9.","DOI":"10.1016\/s0140-6736(17)32714-9"},{"key":"1763_CR21","volume-title":"Coronary Artery Bypass Graft","author":"BJ Bachar","year":"2023","unstructured":"Bachar BJ, Manna B. Coronary Artery Bypass Graft. Treasure Island (FL): StatPearls Publishing; 2023."},{"issue":"6","key":"1763_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3892\/etm.2022.11357","volume":"23","author":"J He","year":"2022","unstructured":"He J, Liu D, Zhao L, Zhou D, Rong J, Zhang L, Xia Z. Myocardial ischemia\/reperfusion injury: Mechanisms of injury and implications for management (Review). Exp Ther Med. 2022;23(6):430. https:\/\/doi.org\/10.3892\/etm.2022.11357.","journal-title":"Exp Ther Med"},{"key":"1763_CR23","doi-asserted-by":"publisher","unstructured":"Roolvink V, Ib\u00e1\u00f1ez B, Ottervanger JP, Pizarro G, van Royen N, Mateos A, \u2026 van 't Hof AWJ. Early intravenous beta-blockers in patients\u00a0with st-segment elevation myocardial infarction before primary percutaneous coronary intervention. J Am Coll Cardiol. 2016;67(23):2705\u20132715. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.522.","DOI":"10.1016\/j.jacc.2016.03.522"},{"issue":"1","key":"1763_CR24","doi-asserted-by":"publisher","first-page":"11859","DOI":"10.1038\/s41598-017-12366-8","volume":"7","author":"C Zhang","year":"2017","unstructured":"Zhang C, He S, Li Y, Li F, Liu Z, Liu J, Gong J. Bisoprolol protects myocardium cells against ischemia\/reperfusion injury by attenuating unfolded protein response in rats. Sci Rep. 2017;7(1):11859. https:\/\/doi.org\/10.1038\/s41598-017-12366-8.","journal-title":"Sci Rep"},{"key":"1763_CR25","unstructured":"Fathima, Syeda Nishat. An update on myocardial infarction. Current Research and Trends Medical Science and Technolnology. 2021;1:216."},{"issue":"11","key":"1763_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/medicina55110721","volume":"55","author":"RN Horodinschi","year":"2019","unstructured":"Horodinschi RN, Stanescu AMA, Bratu OG, Pantea Stoian A, Radavoi DG, Diaconu CC. Treatment with statins in elderly patients. Medicina (Kaunas). 2019;55(11):721. https:\/\/doi.org\/10.3390\/medicina55110721.","journal-title":"Medicina (Kaunas)"},{"issue":"12","key":"1763_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/emmm.201100175","volume":"3","author":"ML Steinhauser","year":"2011","unstructured":"Steinhauser ML, Lee RT. Regeneration of the heart. EMBO Mol Med. 2011;3(12):701\u201312. https:\/\/doi.org\/10.1002\/emmm.201100175.","journal-title":"EMBO Mol Med"},{"key":"1763_CR28","doi-asserted-by":"publisher","unstructured":"Zhuo D, Lei I, Li W, Liu L, Li L, Ni J, \u2026 Fan G. The origin, progress, and application of cell-based cardiac regeneration therapy. J Cell Physiol. 2023;238(8):1732\u20131755. https:\/\/doi.org\/10.1002\/jcp.31060.","DOI":"10.1002\/jcp.31060"},{"key":"1763_CR29","doi-asserted-by":"publisher","unstructured":"Menasch\u00e9 P, Hag\u00e8ge AA, Vilquin J.-T, Desnos M, Abergel E, Pouzet B, \u2026 Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol. 2003;41(7):1078\u20131083. https:\/\/doi.org\/10.1016\/S0735-1097(03)00092-5.","DOI":"10.1016\/S0735-1097(03)00092-5"},{"key":"1763_CR30","doi-asserted-by":"publisher","unstructured":"Valina C, Pinkernell K, Song Y.-H, Bai X, Sadat S, Campeau RJ, \u2026 Alt E. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J. 2007;28(21):2667\u20132677. https:\/\/doi.org\/10.1093\/eurheartj\/ehm426","DOI":"10.1093\/eurheartj\/ehm426"},{"key":"1763_CR31","doi-asserted-by":"publisher","unstructured":"Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE., Berman D, \u2026 Marb\u00e1n E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379(9819):895\u2013904. https:\/\/doi.org\/10.1016\/s0140-6736(12)60195-0.","DOI":"10.1016\/s0140-6736(12)60195-0"},{"issue":"3","key":"1763_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/circresaha.110.227512","volume":"111","author":"CL Mummery","year":"2012","unstructured":"Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res. 2012;111(3):344\u201358. https:\/\/doi.org\/10.1161\/circresaha.110.227512.","journal-title":"Circ Res"},{"issue":"1","key":"1763_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13287-020-01648-0","volume":"11","author":"LC Liew","year":"2020","unstructured":"Liew LC, Ho BX, Soh B-S. Mending a broken heart: current strategies and limitations of cell-based therapy. Stem Cell Res Ther. 2020;11(1):138. https:\/\/doi.org\/10.1186\/s13287-020-01648-0.","journal-title":"Stem Cell Res Ther"},{"key":"1763_CR34","doi-asserted-by":"publisher","first-page":"2729377","DOI":"10.1155\/2023\/2729377","volume":"2023","author":"I Deszcz","year":"2023","unstructured":"Deszcz I. Stem cell-based therapy and cell-free therapy as an alternative approach for cardiac regeneration. Stem Cells Int. 2023;2023:2729377. https:\/\/doi.org\/10.1155\/2023\/2729377.","journal-title":"Stem Cells Int"},{"issue":"10","key":"1763_CR35","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1631\/jzus.2004.1279","volume":"5","author":"J-A Wang","year":"2004","unstructured":"Wang J-A, Li C-L, Fan Y-Q, He H, Sun Y. Allograftic bone marrow-derived mesenchymal stem cells transplanted into heart infarcted model of rabbit to renovate infarcted heart. J Zhejiang Univ-Sci A. 2004;5(10):1279\u201385. https:\/\/doi.org\/10.1631\/jzus.2004.1279.","journal-title":"J Zhejiang Univ-Sci A"},{"issue":"1","key":"1763_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2174\/187152508783329975","volume":"6","author":"C Ventura","year":"2008","unstructured":"Ventura C, Cavallini C, Bianchi F, Cantoni S. Stem cells and cardiovascular repair: a role for natural and synthetic molecules harboring differentiating and paracrine logics. Cardiovasc Hematol Agents Med Chem. 2008;6(1):60\u20138. https:\/\/doi.org\/10.2174\/187152508783329975.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"1763_CR37","doi-asserted-by":"publisher","unstructured":"Amirzadeh gougheri K, Ahmadi A, Ahmadabadi M. G, Babajani A, Yazdanpanah G, Bahrami S, \u2026 Niknejad H. Exosomal Cargo: Pro-angiogeneic, anti-inflammatory, and regenerative effects in ischemic and non-ischemic heart diseases \u2013 A comprehensive review. Biomed Pharmacother. 2023;168:115801. https:\/\/doi.org\/10.1016\/j.biopha.2023.115801.","DOI":"10.1016\/j.biopha.2023.115801"},{"issue":"3","key":"1763_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","volume":"142","author":"M Ieda","year":"2010","unstructured":"Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010;142(3):375\u201386. https:\/\/doi.org\/10.1016\/j.cell.2010.07.002.","journal-title":"Cell"},{"key":"1763_CR39","doi-asserted-by":"publisher","unstructured":"Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, \u2026 Olson EN. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 2012;485(7400):599\u2013604. https:\/\/doi.org\/10.1038\/nature11139.","DOI":"10.1038\/nature11139"},{"issue":"9","key":"1763_CR40","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nrd.2016.89","volume":"15","author":"RG Gourdie","year":"2016","unstructured":"Gourdie RG, Dimmeler S, Kohl P. Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug Discov. 2016;15(9):620\u201338. https:\/\/doi.org\/10.1038\/nrd.2016.89.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"1763_CR41","doi-asserted-by":"publisher","first-page":"e14020","DOI":"10.1111\/acel.14020","volume":"22","author":"MS Allemann","year":"2023","unstructured":"Allemann MS, Lee P, Beer JH, Saeedi Saravi SS. Targeting the redox system for cardiovascular regeneration in aging. Aging Cell. 2023;22(12):e14020. https:\/\/doi.org\/10.1111\/acel.14020.","journal-title":"Aging Cell"},{"issue":"9","key":"1763_CR42","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/bph.14155","volume":"175","author":"S Huang","year":"2018","unstructured":"Huang S, Frangogiannis NG. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. Br J Pharmacol. 2018;175(9):1377\u2013400. https:\/\/doi.org\/10.1111\/bph.14155.","journal-title":"Br J Pharmacol"},{"key":"1763_CR43","doi-asserted-by":"publisher","unstructured":"Han D, Wang F, Qiao Z, Wang B, Zhang Y, Jiang Q, \u2026 Shen D. Neutrophil membrane-camouflaged nanoparticles alleviate inflammation and promote angiogenesis in ischemic myocardial injury. Bioact Mater. 2023;23:369\u2013382. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.11.016.","DOI":"10.1016\/j.bioactmat.2022.11.016"},{"issue":"2","key":"1763_CR44","doi-asserted-by":"publisher","first-page":"H278","DOI":"10.1152\/ajpheart.00471.2017","volume":"314","author":"Y Oduk","year":"2018","unstructured":"Oduk Y, Zhu W, Kannappan R, Zhao M, Borovjagin AV, Oparil S, Zhang J. VEGF nanoparticles repair the heart after myocardial infarction. Am J Physiol-Heart Circulat Physiol. 2018;314(2):H278\u201384. https:\/\/doi.org\/10.1152\/ajpheart.00471.2017.","journal-title":"Am J Physiol-Heart Circulat Physiol"},{"issue":"2","key":"1763_CR45","doi-asserted-by":"publisher","first-page":"H278","DOI":"10.1152\/ajpheart.00471.2017","volume":"314","author":"Y Oduk","year":"2018","unstructured":"Oduk Y, Zhu W, Kannappan R, Zhao M, Borovjagin AV, Oparil S, Zhang JJ. VEGF nanoparticles repair the heart after myocardial infarction. Am J Physiol Heart Circ Physiol. 2018;314(2):H278-h284. https:\/\/doi.org\/10.1152\/ajpheart.00471.2017.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"1763_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0090-9556(24)11823-5","volume":"27","author":"RJ Laham","year":"1999","unstructured":"Laham RJ, Rezaee M, Post M, Sellke FW, Braeckman RA, Hung D, Simons M. Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution. Drug Metab Dispos. 1999;27(7):821\u20136.","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"1763_CR47","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1161\/01.CIR.90.5.2439","volume":"90","author":"LD Horwitz","year":"1994","unstructured":"Horwitz LD, Kaufman D, Keller MW, Kong Y. Time course of coronary endothelial healing after injury due to ischemia and reperfusion. Circulation. 1994;90(5):2439\u201347. https:\/\/doi.org\/10.1161\/01.CIR.90.5.2439.","journal-title":"Circulation"},{"key":"1763_CR48","doi-asserted-by":"publisher","unstructured":"Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP. Recent advances in tumor targeting via EPR Effect for cancer treatment. J Pers Med. 2021;11(6). https:\/\/doi.org\/10.3390\/jpm11060571.","DOI":"10.3390\/jpm11060571"},{"key":"1763_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2017.06.013","volume":"261","author":"M Durymanov","year":"2017","unstructured":"Durymanov M, Kamaletdinova T, Lehmann SE, Reineke J. Exploiting passive nanomedicine accumulation at sites of enhanced vascular permeability for non-cancerous applications. J Control Release. 2017;261:10\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2017.06.013.","journal-title":"J Control Release"},{"issue":"5","key":"1763_CR50","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/pharmaceutics14050930","volume":"14","author":"TA George","year":"2022","unstructured":"George TA, Hsu C-C, Meeson A, Lundy DJ. Nanocarrier-based targeted therapies for myocardial infarction. Pharmaceutics. 2022;14(5):930.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1763_CR51","doi-asserted-by":"publisher","first-page":"25613","DOI":"10.1038\/srep25613","volume":"6","author":"DJ Lundy","year":"2016","unstructured":"Lundy DJ, Chen K-H, Toh EKW, Hsieh PCH. Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury. Sci Rep. 2016;6(1):25613. https:\/\/doi.org\/10.1038\/srep25613.","journal-title":"Sci Rep"},{"issue":"4","key":"1763_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrd4503","volume":"14","author":"CJ Cheng","year":"2015","unstructured":"Cheng CJ, Tietjen GT, Saucier-Sawyer JK, Saltzman WM. A holistic approach to targeting disease with polymeric nanoparticles. Nat Rev Drug Discovery. 2015;14(4):239\u201347. https:\/\/doi.org\/10.1038\/nrd4503.","journal-title":"Nat Rev Drug Discovery"},{"issue":"4","key":"1763_CR53","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40005-019-00443-1","volume":"49","author":"F Emami","year":"2019","unstructured":"Emami F, Mostafavi Yazdi SJ, Na DH. Poly(lactic acid)\/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery. J Pharm Investig. 2019;49(4):427\u201342. https:\/\/doi.org\/10.1007\/s40005-019-00443-1.","journal-title":"J Pharm Investig"},{"issue":"4","key":"1763_CR54","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1536\/ihj.16-457","volume":"58","author":"Y Mao","year":"2017","unstructured":"Mao Y, Koga JI, Tokutome M, Matoba T, Ikeda G, Nakano K, Egashira K. Nanoparticle-mediated delivery of pitavastatin to monocytes\/macrophages inhibits left ventricular remodeling after acute myocardial infarction by inhibiting monocyte-mediated inflammation. Int Heart J. 2017;58(4):615\u201323. https:\/\/doi.org\/10.1536\/ihj.16-457.","journal-title":"Int Heart J"},{"key":"1763_CR55","doi-asserted-by":"publisher","unstructured":"Zhou Z, Li D, Zhou H, Lin X, Li C, Tang M, \u2026 Li M. Plants and their bioactive compounds with the potential to enhance mechanisms of inherited cardiac regeneration. Planta Med. 2015;81(8):637\u2013647. https:\/\/doi.org\/10.1055\/s-0035-1545946.","DOI":"10.1055\/s-0035-1545946"},{"key":"1763_CR56","doi-asserted-by":"publisher","unstructured":"Nabofa WEE, Alashe OO, Oyeyemi OT, Attah AF, Oyagbemi AA, Omobowale TO, \u2026 Alada ARA. Cardioprotective effects of curcumin-nisin based poly lactic acid nanoparticle on myocardial infarction in guinea pigs. Sci Rep. 2018;8(1):16649. https:\/\/doi.org\/10.1038\/s41598-018-35145-5.","DOI":"10.1038\/s41598-018-35145-5"},{"key":"1763_CR57","doi-asserted-by":"publisher","first-page":"110635","DOI":"10.1016\/j.colsurfb.2019.110635","volume":"185","author":"W Bei","year":"2019","unstructured":"Bei W, Jing L, Chen N. Cardio protective role of wogonin loaded nanoparticle against isoproterenol induced myocardial infarction by moderating oxidative stress and inflammation. Colloids Surf, B. 2019;185:110635. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110635.","journal-title":"Colloids Surf, B"},{"issue":"9","key":"1763_CR58","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1021\/acs.nanolett.8b02578","volume":"18","author":"T Bejerano","year":"2018","unstructured":"Bejerano T, Etzion S, Elyagon S, Etzion Y, Cohen S. Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction. Nano Lett. 2018;18(9):5885\u201391. https:\/\/doi.org\/10.1021\/acs.nanolett.8b02578.","journal-title":"Nano Lett"},{"key":"1763_CR59","doi-asserted-by":"publisher","unstructured":"Rahnavard M, Hassanpour M, Ahmadi M, Heidarzadeh M, Amini H, Javanmard MZ, \u2026 Safaie N. Curcumin ameliorated myocardial infarction by inhibition of cardiotoxicity in the rat model. J Cell Biochem. 2019;120(7):11965\u201311972. https:\/\/doi.org\/10.1002\/jcb.28480.","DOI":"10.1002\/jcb.28480"},{"key":"1763_CR60","doi-asserted-by":"publisher","unstructured":"Boarescu PM, Boarescu I, Boc\u0219an IC, Gheban D, Bulboac\u0103 AE, Nicula C, \u2026 Bolboac\u0103 SD. Antioxidant and anti-inflammatory effects of curcumin nanoparticles on drug-induced acute myocardial infarction in diabetic rats. Antioxidants (Basel). 2019; 8(10). https:\/\/doi.org\/10.3390\/antiox8100504.","DOI":"10.3390\/antiox8100504"},{"key":"1763_CR61","doi-asserted-by":"publisher","first-page":"7847142","DOI":"10.1155\/2019\/7847142","volume":"2019","author":"PM Boarescu","year":"2019","unstructured":"Boarescu PM, Chiril\u0103 I, Bulboac\u0103 AE, Boc\u0219an IC, Pop RM, Gheban D, Bolboac\u0103 SD. Effects of curcumin nanoparticles in isoproterenol-induced myocardial infarction. Oxid Med Cell Longev. 2019;2019:7847142. https:\/\/doi.org\/10.1155\/2019\/7847142.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"1763_CR62","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/ijms25021001","volume":"25","author":"A Scafa Udri\u0219te","year":"2024","unstructured":"Scafa Udri\u0219te A, Burdu\u0219el AC, Niculescu A-G, R\u0103dulescu M, Grumezescu AM. Metal-based nanoparticles for cardiovascular diseases. Int J Mol Sci. 2024;25(2):1001.","journal-title":"Int J Mol Sci"},{"key":"1763_CR63","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.nano.2021.102433","volume":"36","author":"NK Younis","year":"2021","unstructured":"Younis NK, Ghoubaira JA, Bassil EP, Tantawi HN, Eid AH. Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases. Nanomedicine: Nanotechnol Biol Med. 2021;36:102433. https:\/\/doi.org\/10.1016\/j.nano.2021.102433.","journal-title":"Nanomedicine: Nanotechnol Biol Med"},{"key":"1763_CR64","doi-asserted-by":"publisher","unstructured":"Tian A, Yang C, Zhu B, Wang W, Liu K, Jiang Y, \u2026 Li Z. Polyethylene-glycol-coated gold nanoparticles improve cardiac function after myocardial infarction in mice. Can J Physiol Pharmacol. 2018;96(12):1318\u20131327. https:\/\/doi.org\/10.1139\/cjpp-2018-0227","DOI":"10.1139\/cjpp-2018-0227"},{"key":"1763_CR65","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3389\/fbioe.2020.00687","volume":"8","author":"C Fan","year":"2020","unstructured":"Fan C, Joshi J, Li F, Xu B, Khan M, Yang J, Zhu W. Nanoparticle-mediated drug delivery for treatment of ischemic heart disease. Front Bioeng Biotechnol. 2020;8:687. https:\/\/doi.org\/10.3389\/fbioe.2020.00687.","journal-title":"Front Bioeng Biotechnol"},{"issue":"9","key":"1763_CR66","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1080\/10717544.2016.1223218","volume":"23","author":"S Zhang","year":"2016","unstructured":"Zhang S, Wang J, Pan J. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv. 2016;23(9):3696\u2013703. https:\/\/doi.org\/10.1080\/10717544.2016.1223218.","journal-title":"Drug Deliv"},{"key":"1763_CR67","doi-asserted-by":"publisher","unstructured":"Allijn IE, Czarny BMS, Wang X, Chong SY, Weiler M, da Silva AE, \u2026 Schiffelers RM. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. J Controll Release. 2017; 247:127\u2013133. https:\/\/doi.org\/10.1016\/j.jconrel.2016.12.042.","DOI":"10.1016\/j.jconrel.2016.12.042"},{"issue":"3","key":"1763_CR68","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/biof.1611","volume":"46","author":"L Sun","year":"2020","unstructured":"Sun L, Hu Y, Mishra A, Sreeharsha N, Moktan JB, Kumar P, Wang L. Protective role of poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol against isoproterenol-induced myocardial infarction. BioFactors. 2020;46(3):421\u201331. https:\/\/doi.org\/10.1002\/biof.1611.","journal-title":"BioFactors"},{"issue":"sup3","key":"1763_CR69","doi-asserted-by":"publisher","first-page":"S707","DOI":"10.1080\/21691401.2018.1508028","volume":"46","author":"S Mao","year":"2018","unstructured":"Mao S, Wang L, Chen P, Lan Y, Guo R, Zhang M. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-\u03baB pathway. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S707-s716. https:\/\/doi.org\/10.1080\/21691401.2018.1508028.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"1763_CR70","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/01913123.2017.1281367","volume":"41","author":"SM Ahmed","year":"2017","unstructured":"Ahmed SM, Abdelrahman SA, Salama AE. Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats. Ultrastruct Pathol. 2017;41(2):168\u201385. https:\/\/doi.org\/10.1080\/01913123.2017.1281367.","journal-title":"Ultrastruct Pathol"},{"key":"1763_CR71","doi-asserted-by":"publisher","first-page":"867497","DOI":"10.3389\/fmed.2022.867497","volume":"9","author":"W Arozal","year":"2022","unstructured":"Arozal W, Monayo ER, Barinda AJ, Perkasa DP, Soetikno V, Nafrialdi N, Louisa M. Protective effects of silver nanoparticles in isoproterenol-induced myocardial infarction in rats. Frontiers in Medicine. 2022;9:867497. https:\/\/doi.org\/10.3389\/fmed.2022.867497.","journal-title":"Frontiers in Medicine"},{"issue":"7","key":"1763_CR72","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.cir.0000051363.86009.3c","volume":"107","author":"M Sun","year":"2003","unstructured":"Sun M, Opavsky MA, Stewart DJ, Rabinovitch M, Dawood F, Wen WH, Liu PP. Temporal response and localization of integrins beta1 and beta3 in the heart after myocardial infarction: regulation by cytokines. Circulation. 2003;107(7):1046\u201352. https:\/\/doi.org\/10.1161\/01.cir.0000051363.86009.3c.","journal-title":"Circulation"},{"key":"1763_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.biopha.2017.02.029","volume":"89","author":"Z Dong","year":"2017","unstructured":"Dong Z, Guo J, Xing X, Zhang X, Du Y, Lu Q. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother. 2017;89:297\u2013304. https:\/\/doi.org\/10.1016\/j.biopha.2017.02.029.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1763_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2015.06.029","volume":"569","author":"W Song","year":"2015","unstructured":"Song W, Wang H, Wu Q. Atrial natriuretic peptide in cardiovascular biology and disease (NPPA). Gene. 2015;569(1):1\u20136. https:\/\/doi.org\/10.1016\/j.gene.2015.06.029.","journal-title":"Gene"},{"key":"1763_CR75","doi-asserted-by":"publisher","unstructured":"Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol. 2009;(191):341\u2013366. https:\/\/doi.org\/10.1007\/978-3-540-68964-5_15.","DOI":"10.1007\/978-3-540-68964-5_15"},{"issue":"3","key":"1763_CR76","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2217\/fca-2017-0012","volume":"13","author":"SB Ong","year":"2017","unstructured":"Ong SB, Lu S, Katwadi K, Ismail NI, Kwek XY, Hausenloy DJ. Nanoparticle delivery of mitoprotective agents to target ischemic heart disease. Future Cardiol. 2017;13(3):195\u20138. https:\/\/doi.org\/10.2217\/fca-2017-0012.","journal-title":"Future Cardiol"},{"issue":"1","key":"1763_CR77","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1080\/10717544.2021.1989086","volume":"28","author":"J Wang","year":"2021","unstructured":"Wang J, Zhang S, Di L. Acute myocardial infarction therapy: in vitro and in vivo evaluation of atrial natriuretic peptide and triphenylphosphonium dual ligands modified, baicalin-loaded nanoparticulate system. Drug Deliv. 2021;28(1):2198\u2013204. https:\/\/doi.org\/10.1080\/10717544.2021.1989086.","journal-title":"Drug Deliv"},{"issue":"3","key":"1763_CR78","first-page":"276","volume":"14","author":"A Yabluchanskiy","year":"2013","unstructured":"Yabluchanskiy A, Li Y, Chilton RJ, Lindsey ML. Matrix metalloproteinases: drug targets for myocardial infarction. Curr Drug Targets. 2013;14(3):276\u201386.","journal-title":"Curr Drug Targets"},{"key":"1763_CR79","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.2147\/ijn.s141549","volume":"12","author":"M Shao","year":"2017","unstructured":"Shao M, Yang W, Han G. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles. Int J Nanomedicine. 2017;12:7121\u201330. https:\/\/doi.org\/10.2147\/ijn.s141549.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1763_CR80","doi-asserted-by":"publisher","first-page":"20200137","DOI":"10.1002\/VIW.20200137","volume":"3","author":"C Li","year":"2022","unstructured":"Li C, Wu P, Dou Y, Li Q, Zhang J. Bioresponsive nanoplatforms for imaging and therapy of cardiovascular diseases. VIEW. 2022;3(1):20200137. https:\/\/doi.org\/10.1002\/VIW.20200137.","journal-title":"VIEW"},{"key":"1763_CR81","doi-asserted-by":"publisher","unstructured":"Wang L, Peng Y, Song L, Xia D, Li C, Li Z, \u2026 Wang Y. Colchicine-containing nanoparticles attenuates acute myocardial infarction injury by inhibiting inflammation. Cardiovasc Drugs Ther. 2022;36(6):1075\u20131089. https:\/\/doi.org\/10.1007\/s10557-021-07239-2.","DOI":"10.1007\/s10557-021-07239-2"},{"key":"1763_CR82","unstructured":"Sawant, P., Lipoprotein nanoparticles and their role in cardiovascular disease management\u2013a review. BAOJ Nanotechnology. 2016;1(006)."},{"issue":"4","key":"1763_CR83","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/MOL.0b013e32833bcdc1","volume":"21","author":"A Kontush","year":"2010","unstructured":"Kontush A, Chapman MJ. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol. 2010;21(4):312\u20138. https:\/\/doi.org\/10.1097\/MOL.0b013e32833bcdc1.","journal-title":"Curr Opin Lipidol"},{"key":"1763_CR84","doi-asserted-by":"publisher","unstructured":"de Lima AD, Guido MC, Tavares ER, Carvalho PO, Marques AF, de Melo MDT, \u2026 Maranh\u00e3o RC. The expression of lipoprotein receptors is increased in the infarcted area after myocardial infarction induced in rats with cardiac dysfunction. Lipids. 2018;53(2):177\u2013187. https:\/\/doi.org\/10.1002\/lipd.12014.","DOI":"10.1002\/lipd.12014"},{"key":"1763_CR85","doi-asserted-by":"publisher","unstructured":"Richart AL, Reddy M, Khalaji M, Natoli AL, Heywood SE, Siebel AL, \u2026 Kingwell BA. Apo AI nanoparticles delivered post myocardial infarction moderate inflammation. Circ Res. 2020;127(11):1422\u20131436. https:\/\/doi.org\/10.1161\/circresaha.120.316848.","DOI":"10.1161\/circresaha.120.316848"},{"issue":"3","key":"1763_CR86","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2217\/17435889.2.3.375","volume":"2","author":"IR Corbin","year":"2007","unstructured":"Corbin IR, Zheng G. Mimicking nature\u2019s nanocarrier: synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery. Nanomedicine (Lond). 2007;2(3):375\u201380. https:\/\/doi.org\/10.2217\/17435889.2.3.375.","journal-title":"Nanomedicine (Lond)"},{"issue":"12","key":"1763_CR87","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s11745-017-4306-6","volume":"52","author":"EN Daminelli","year":"2017","unstructured":"Daminelli EN, Fotakis P, Mesquita CH, Maranh\u00e3o RC, Zannis VI. Tissue uptake mechanisms involved in the clearance of non-protein nanoparticles that mimic LDL composition: a study with knockout and transgenic mice. Lipids. 2017;52(12):991\u20138. https:\/\/doi.org\/10.1007\/s11745-017-4306-6.","journal-title":"Lipids"},{"issue":"8","key":"1763_CR88","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/bf02535988","volume":"28","author":"RC Maranh\u00e3o","year":"1993","unstructured":"Maranh\u00e3o RC, Cesar TB, Pedroso-Mariani SR, Hirata MH, Mesquita CH. Metabolic behavior in rats of a nonprotein microemulsion resembling low-density lipoprotein. Lipids. 1993;28(8):691\u20136. https:\/\/doi.org\/10.1007\/bf02535988.","journal-title":"Lipids"},{"key":"1763_CR89","doi-asserted-by":"publisher","unstructured":"Maranh\u00e3o RC, Guido MC, de Lima AD, Tavares ER, Marques AF, Tavares de Melo MD, \u2026 Kalil-Filho R. Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats. Int J Nanomed. 2017;12:3767\u20133784. https:\/\/doi.org\/10.2147\/ijn.s129324.","DOI":"10.2147\/ijn.s129324"},{"key":"1763_CR90","doi-asserted-by":"crossref","unstructured":"Haider KH, Najimi M. Exosome-based cell-free therapy in regenerative medicine for myocardial repair. Handbook of stem cell therapy (pp 1007\u20131034): Springer. 2022.","DOI":"10.1007\/978-981-19-2655-6_42"},{"issue":"7","key":"1763_CR91","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/cbin.11515","volume":"45","author":"P Koohsarian","year":"2021","unstructured":"Koohsarian P, Talebi A, Rahnama MA, Zomorrod MS, Kaviani S, Jalili A. Reviewing the role of cardiac exosomes in myocardial repair at a glance. Cell Biol Int. 2021;45(7):1352\u201363. https:\/\/doi.org\/10.1002\/cbin.11515.","journal-title":"Cell Biol Int"},{"key":"1763_CR92","doi-asserted-by":"publisher","unstructured":"Huang P, Wang L, Li Q, Tian X, Xu J, Xu J, \u2026 Yang Y. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020;116(2):353\u2013367. https:\/\/doi.org\/10.1093\/cvr\/cvz139.","DOI":"10.1093\/cvr\/cvz139"},{"issue":"11","key":"1763_CR93","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.3390\/molecules26113428","volume":"26","author":"C Zhu","year":"2021","unstructured":"Zhu C, Ma J, Ji Z, Shen J, Wang Q. Recent advances of cell membrane coated nanoparticles in treating cardiovascular disorders. Molecules. 2021;26(11):3428. https:\/\/doi.org\/10.3390\/molecules26113428.","journal-title":"Molecules"},{"key":"1763_CR94","doi-asserted-by":"publisher","unstructured":"Torrieri G, Fontana F, Figueiredo P, Liu Z, Ferreira MPA, Talman V, \u2026 Santos H. Dual-Peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction. Nanoscale. 2019. https:\/\/doi.org\/10.1039\/C9NR09934D.","DOI":"10.1039\/C9NR09934D"},{"key":"1763_CR95","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.2147\/ijn.s165590","volume":"13","author":"S Zhang","year":"2018","unstructured":"Zhang S, Li J, Hu S, Wu F, Zhang X. Triphenylphosphonium and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction. Int J Nanomedicine. 2018;13:4045\u201357. https:\/\/doi.org\/10.2147\/ijn.s165590.","journal-title":"Int J Nanomedicine"},{"issue":"3\u20134","key":"1763_CR96","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/107632704323061762","volume":"10","author":"KL Christman","year":"2004","unstructured":"Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004;10(3\u20134):403\u20139. https:\/\/doi.org\/10.1089\/107632704323061762.","journal-title":"Tissue Eng"},{"key":"1763_CR97","doi-asserted-by":"publisher","unstructured":"Kofidis T, de Bruin JL, Hoyt G, Lebl DR, Tanaka M, Yamane T, \u2026 Robbins RC. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg. 2004;128(4):571\u2013578. https:\/\/doi.org\/10.1016\/j.jtcvs.2004.05.021.","DOI":"10.1016\/j.jtcvs.2004.05.021"},{"issue":"5","key":"1763_CR98","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12265-010-9202-x","volume":"3","author":"JM Singelyn","year":"2010","unstructured":"Singelyn JM, Christman KL. Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J Cardiovasc Transl Res. 2010;3(5):478\u201386. https:\/\/doi.org\/10.1007\/s12265-010-9202-x.","journal-title":"J Cardiovasc Transl Res"},{"issue":"12","key":"1763_CR99","doi-asserted-by":"publisher","first-page":"943","DOI":"10.4070\/kcj.2021.0291","volume":"51","author":"S Vasu","year":"2021","unstructured":"Vasu S, Zhou J, Chen J, Johnston PV, Kim D-H. Biomaterials-based approaches for cardiac regeneration. kcj. 2021;51(12):943\u201360. https:\/\/doi.org\/10.4070\/kcj.2021.0291.","journal-title":"kcj"},{"issue":"2","key":"1763_CR100","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1021\/acsbiomaterials.9b01758","volume":"6","author":"AJ Rocker","year":"2020","unstructured":"Rocker AJ, Lee DJ, Shandas R, Park D. Injectable polymeric delivery system for spatiotemporal and sequential release of therapeutic proteins to promote therapeutic angiogenesis and reduce inflammation. ACS Biomater Sci Eng. 2020;6(2):1217\u201327. https:\/\/doi.org\/10.1021\/acsbiomaterials.9b01758.","journal-title":"ACS Biomater Sci Eng"},{"key":"1763_CR101","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cis.2016.12.005","volume":"240","author":"DJ McClements","year":"2017","unstructured":"McClements DJ. Designing biopolymer microgels to encapsulate, protect and deliver bioactive components: Physicochemical aspects. Adv Coll Interface Sci. 2017;240:31\u201359. https:\/\/doi.org\/10.1016\/j.cis.2016.12.005.","journal-title":"Adv Coll Interface Sci"},{"key":"1763_CR102","doi-asserted-by":"publisher","unstructured":"Chen J, Han X, Deng J, Zhang J, Li L, Ni J, \u2026 Fan G. An injectable hydrogel based on phenylboronic acid hyperbranched macromer encapsulating gold nanorods and Astragaloside IV nanodrug for myocardial infarction. Chem Eng J. 2021;413:127423. https:\/\/doi.org\/10.1016\/j.cej.2020.127423.","DOI":"10.1016\/j.cej.2020.127423"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01763-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:25:18Z","timestamp":1749039918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01763-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":102,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01763-y","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"6 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}]}}